Collegium Pharmaceutical News - COLL

Company Name	Stock Ticker Symbol	Market	Type
Collegium Pharmaceutical Inc	COLL	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	1.56	4.49%	36.30	15:11:59

Open Price	Low Price	High Price	Close Price	Prev Close
35.00	34.9226	36.5054		34.74

more quote information »

Recent News

Date	Time	Source	Heading
4/11/2024	08:00	GLOBE	Collegium Pharmaceutical, Inc. Announces Redemption of..
4/03/2024	08:00	GLOBE	Collegium to Participate in 23rd Annual Needham Virtual..
3/04/2024	16:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	17:24	EDGAR2	Form 144 - Report of proposed sale of securities
2/26/2024	16:39	EDGAR2	Form 144 - Report of proposed sale of securities
2/22/2024	16:09	GLOBE	Collegium Reports Record Fourth Quarter and Full-Year 2023..
2/22/2024	16:03	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/22/2024	16:01	EDGAR2	Form 8-K - Current report
2/14/2024	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	12:04	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/08/2024	08:00	GLOBE	Collegium to Report Fourth Quarter and Full-Year 2023..
1/18/2024	16:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/16/2024	16:20	EDGAR2	Form 144 - Report of proposed sale of securities
1/03/2024	08:03	EDGAR2	Form 8-K - Current report
1/03/2024	08:00	GLOBE	Collegium Provides 2024 Financial Guidance
12/22/2023	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/21/2023	16:15	EDGAR2	Form 144 - Report of proposed sale of securities
12/20/2023	17:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	16:28	EDGAR2	Form 144 - Report of proposed sale of securities
12/19/2023	16:13	EDGAR2	Form 144 - Report of proposed sale of securities
12/18/2023	16:11	EDGAR2	Form 144 - Report of proposed sale of securities
11/29/2023	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/27/2023	17:00	EDGAR2	Form 144 - Report of proposed sale of securities
11/27/2023	08:00	GLOBE	Appeals Court Upholds PTAB’s Finding of Invalidity of..
11/09/2023	08:05	EDGAR2	Form 8-K - Current report
11/09/2023	08:00	GLOBE	Collegium Announces $25 Million Accelerated Share Repurchase..
11/08/2023	08:00	GLOBE	Collegium to Participate in Upcoming Investor Conferences
11/07/2023	16:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	16:01	EDGAR2	Form 8-K - Current report
11/07/2023	16:01	GLOBE	Collegium Reports Third Quarter 2023 Financial Results
10/24/2023	08:00	GLOBE	Collegium to Report Third Quarter 2023 Financial Results on..
8/28/2023	08:00	GLOBE	Collegium Announces 10 Poster Presentations at PAINWeek..
8/24/2023	08:05	EDGAR2	Form 8-K - Current report
8/24/2023	08:00	GLOBE	Collegium Announces Extension of Nucynta Regulatory..
8/10/2023	16:06	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/07/2023	07:40	EDGAR2	Form 8-K - Current report
8/07/2023	07:30	GLOBE	Collegium Announces $50 Million Accelerated Share Repurchase..
8/03/2023	16:03	EDGAR2	Form 8-K - Current report
8/03/2023	16:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	16:01	GLOBE	Collegium Reports Record 1H’23 Net Revenue of $280.3..
7/20/2023	08:00	GLOBE	Collegium to Report Second Quarter 2023 Financial Results on..
6/28/2023	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/01/2023	08:00	GLOBE	Collegium to Participate in Jefferies Healthcare Conference
5/04/2023	16:01	GLOBE	Collegium Reports First Quarter 2023 Financial Results